Immediate Impact
51 standout
Citing Papers
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
2023 Standout
Deubiquitinases in cancer
2023 Standout
Works of Andrew Brown being referenced
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
2011
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrew Brown | 143 | 132 | 72 | 109 | 12 | 396 | |
| Gannong Chen | 98 | 162 | 115 | 43 | 14 | 370 | |
| Jinsong He | 161 | 117 | 27 | 70 | 22 | 405 | |
| Philipp Baumann | 239 | 110 | 32 | 33 | 17 | 426 | |
| D. Batchelor | 73 | 184 | 30 | 49 | 9 | 393 | |
| Jeetendra Eswaraka | 131 | 73 | 30 | 31 | 11 | 413 | |
| Yi Tu | 230 | 150 | 43 | 47 | 23 | 423 | |
| S E Honn | 205 | 179 | 63 | 16 | 8 | 458 | |
| Yin Zongyi | 126 | 141 | 105 | 9 | 14 | 427 | |
| Kathryn P Trayes | 86 | 94 | 46 | 31 | 11 | 422 | |
| Jiayi Hu | 81 | 97 | 28 | 34 | 21 | 447 |
All Works
Login with ORCID to disown or claim papers
Loading papers...